Home
About Us
Structure
Current Events
Past Events
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 
The USA-India Chamber of Commerce mission is to provide a pro-active & professional platform for high ranking policy makers, senior business executives, academicians, and investors in the United States and India to network, facilitate and promote trade, investments & economic cooperation. USAIC’s four point agenda is: Trade, Investment, Policy and Advocacy.
 
US-India BioPharma & Healthcare Summit, Thursday, June 11, 2015



Strategy Sessions (By  invitation only)

Cardiovascular & Metabolic Diseases Strategy Session Co-Chairs
John L. Brooks, III Philip J. Larsen, MD, PhD Philip J. Larsen, MD, PhD
John L. Brooks III 
President & CEO
Joslin Diabetes Center
Daniel Bloomfield, MD
Cardiovascular Therapeutic Area Head
Merck Research Laboratories
Philip J. Larsen, MD, PhD
Global Head of Diabetes R&D
Sanofi
 
External R&D Strategies Session Co-Chairs
Sridaran Natesan, PhD Jeffrey S. Nye, MD, PhD Subir K. Basak B.E (Chemical), MS, PhD, MBA
Sridaran Natesan, PhD
Vice President- Strategic Initiatives & Scientific Relations
Sanofi
Jeffrey S. Nye, MD, PhD
Vice President
Neuroscience Innovation & Scientific Partnership Strategy
Johnson and Johnson Innovation
Subir K. Basak B.E (Chemical), PhD
President- Drug Discovery Services
Jubilant Life Sciences


View Event Brochure



USA Indiachamber of Commerce Contact

Schedule

Schedule

Emcee - Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

* Speakers and Timings subject to change
Time Topic
9-00 AM - 9-30 AM Registration and Networking
9-30 AM - 9-35 AM Welcome address by Karun Rishi, President, USA-India Chamber of Commerce
9-35 AM - 9-45 AM Opening comments by Master of Ceremonies - Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School
9-45 AM - 10-10 AM Release of annual Position Paper by Advisory Board members

Presentation of USA-India Chamber of Commerce commissioned annual Position Paper by Dr. Ajay Dhankhar, Director, McKinsey & Company
10-10 AM - 10-40 AM Address by Professor K. VijayRaghavan, Secretary, Department of Biotechnology, Ministry of Science & Technology, Government of India
10-40 AM - 11-30 AM Panel Discussion: Biologics and Biosimilars- How will the future landscape shape out and what are the key challenges to overcome?
Panelists:
  • John Cox, Executive Vice President- Pharma Operations, Biogen Idec
  • Dr. Richard Gregory, Head of R&D, Sanofi-Genzyme R&D Center
  • Dr. Mark Schenerman, VP- Analytical Biotechnology & Strategy, MedImmune
  • Rick Srigley, President & CEO, Aragen Bioscience
  • K.V. Subramaniam, President & CEO, Reliance Life Sciences
Moderator:
Thomas Saylor, Chief Executive Officer, Arecor Limited
11-30 AM -12-00 PM Networking & Tea Break
12-00 PM - 12-50 PM Panel Discussion: Industry-Academia Partnerships- Is there a recipe for successful partnerships?
Panelists:
  • Dr. Karen Antman, Dean and Provost, Boston University School of Medicine
  • Dr. Sumantra Chattarji, NCBS, Director- Center for Brain Development & Repair, India
  • Dr. Laurie Glimcher, Dean, Weill Cornell Medical College
  • Dr. Michael Rosenblatt, Executive Vice President & Chief Medical Officer, Merck & Co.
  • Dr. Lansing Taylor, Director, University of Pittsburgh Drug Discovery Institute
Moderator:
Dr. Dr. William Chin, Executive Vice President- Scientific and Regulatory Affairs, PhRMA
12-50 PM - 2-20 PM Luncheon Panel Discussion:  Reimagining India- Unlocking the potential of Asia’s next superpower
Panelists:
  • Dr. Yasheng Huang, Associate Dean and Professor, Sloan School of Management- MIT
  • Ambassador Dnyaneshwar Mulay, Consul General of India, New York
  • Dr. Prof. K. VijayRaghavan, Secretary, Department of Biotechnology, Govt. of India
  • Dr. Srinath Reddy, President, Public Health Foundation of India
Moderator:
Adil Zainulbhai, Director Emeritus - India Office, McKinsey & Company
2-20 PM - 2-50 PM Networking & Tea Break
2-50 PM - 3-40 PM Panel Discussion: Drug Discovery and Collaborative Research- How can emerging markets play a greater role in BioPharma innovation?
Panelists:
  • Dr. Subir Basak, President- Global Drug Discovery Services, Jubilant Life Sciences
  • Dr. Bahija Jallal, Executive Vice President, MedImmune
  • Manni Kantipudi, Chief Executive Officer, GVK Biosciences
  • Dr. Andrew Plump, Deputy to the President of Global R&D, Sanofi
  • Dr. Tsutomu Une, Corporate Advisor, Daiichi Sankyo Co., Ltd.
Moderator:
Dr. Martin Mackay, Exe. Vice President and Global Head of R&D, Alexion Pharmaceuticals
3-40 PM - 4-30 PM Panel Discussion: Cardiovascular and Metabolic Diseases- Science and research trends- Lessening the disease burden through BioPharma innovation
Panelists:
  • Dr. Caroline Apovian, Professor of Medicine, Section of Endocrinology, BUMC
  • Dr. Daniel Bloomfield, Vice President Clinical Research and  Cardiovascular Therapeutic Area Head, Merck Research Labs
  • John Brooks, President & CEO, Joslin Diabetes Center
  • Dr. Philip Larsen, Global Head of Diabetes R&D, Sanofi
  • Dr. Ming Wang, VP and Disease Area Leader of Diabetes, Janssen Pharmaceuticals
Moderator:
Sri Mosur, President, Stabilis and Founder, Tanroe
4-30 PM - 5-00 PM Introduction to Dr. Robert Langer by: Dr. Sridaran Natesan, Vice President- Strategic Initiatives & Scientific Relations, Sanofi
Address by:
Dr. Robert Langer, David H. Koch Institute Professor, MIT
5-00 PM - 5-05 PM Closing remarks
5-05 PM - 6-30 PM Cocktails & Networking Reception
Please keep your cell phones in the silent mode



USA Indiachamber of Commerce Contact

US-India BioPharma & Healthcare Summit 2015
Date: Thursday, June 11, 2015
Time: 9 AM to 7-30 PM
Location: Grand Ballroom, Marriott Cambridge, Massachusetts, USA
Panel Discussions & Keynotes covering

  • Drug Discovery and Collaborative Research
  • Global CMO panel
  • Therapeutic Area Covering: Oncology. Discussions focused on Science, Research Trends and Investor Perspective
  • Therapeutic Area Covering: Cardiovascular & Metabolic Diseases (Diabetes). Discussions focused on Science, Research Trends and Investor Perspective
  • Therapeutic Area Covering:  CNS diseases. Discussions focused on Science, Research Trends and Investor Perspective
  • Emerging Markets- Opportunities, Challenges & Strategies
  • R&D Challenges and New R&D Models
  • Scientific and Business Model Innovation Trends
  • Industry-Academic Research Partnerships/Translational Research
  • Licensing, IP & Regulatory Issues
  • Funding Innovation, Cross Border Investments and M&A trends in the BioPharma & Healthcare

Breakfast Strategy Sessions (by invitation only):

Networking Tea Breaks, Hosted Lunch, Cocktails & High Power Networking Reception

* Program subject to change

View Event Brochure


USA Indiachamber of Commerce Contact

Some of the Speakers

Dr. Martin Mackay Dr. Michael Rosenblatt Heramb R. Hajarnavis K.V. Subramaniam Andrew S. Plunp
Dr. Martin Mackay
EVP, Global Head of R&D
Alexion Pharmaceuticals
Dr. Michael Rosenblatt
Exe Vice President & CMO
Merck & Co.
Prof. K. Vijay Raghavan* Secretary Department of Biotechnology Prof. Robert S. Langer
David H. Koch Institute Professor, MIT
Andrew Plump, MD, PhD
Deputy to the President of Global R&D, Sanofi
         
Bahija Jallal Laurie H. Glimcher Tsutomu Une K.V. Subramaniam William W. Chin
Bahija Jallal, PhD
Executive Vice President
MedImmune
Laurie Glimcher, MD
Dean
Weill Cornell Medical College
Tsutomu Une, PhD
Corporate Advisor
Daiichi Sankyo
K.V. Subramaniam
President & CEO
Reliance Life Sciences
William Chin, MD
Executive Vice President
PhRMA
 
Caroline Apovian, MD John G. Cox Raju Kucherlapati Philip J. Larsen, MD, PhD Manni Kantipudi
Caroline Apovian, MD
Professor of Medicine
Section of Endocrinology
BU School of Medicine
John G. Cox
Executive Vice President
Biogen Idec
Dr. Raju Kucherlapati
Paul C. Cabot Professor
Department of Genetics
Harvard Medical School
Philip J. Larsen, MD, PhD
Global Head of Diabetes R&D
Sanofi
Manni Kantipudi
Chief Executive Officer
GVK Biosciences
 
Dr. Ming Wang Adil Zainulbhai Sridaran Natesan Daniel Bloomfield Subir K. Basak
Dr. Ming Wang
Vice President and Disease Area Leader of Diabetes
Janssen Pharmaceuticals
Adil Zainulbhai
Director Emeritus - India
McKinsey & Company
Sridaran Natesan, PhD
VP - Strategic Initiatives & Scientific Relations
Sanofi
Daniel Bloomfield, MD
Cardiovascular Therapeutic Area Head
Merck Research Laboratories
Subir Basak, PhD
President - DDS
Jubilant Life Sciences
 
Richard Gregory Karen H. Antman Rick Srigley Yasheng Huang John L. Brooks
Richard Gregory, PhD
Head of R&D
Sanofi-Genzyme R&D Center
Ajay Dhankhar, PhD
Director
McKinsey and Company
Rick Srigley
President & CEO
Aragen Bioscience
Yasheng Huang, PhD
Associate Dean and Professor
Sloan School of Management (MIT)
John L. Brooks III
President & CEO
Joslin Diabetes Center
         
Mark Schenerman D. Lansing Taylor Thomas Reese Saylor Prof. K. Srinath Reddy Karen H. Antman
Mark Schenerman, PhD
Vice President - Analytical Biotechnology & Strategy
MedImmune
D. Lansing Taylor, PhD
Director of the University of Pittsburgh Drug Discovery Institute
Thomas Reese Saylor
Chief Executive Officer
Arecor Limited
Prof. K. Srinath Reddy
President
Public Health Foundation of India
Dr. Karen H. Antman
Dean & Provost Boston Univ School of Medicine
 
Jeffrey S. Nye, MD, PhD Sridhar Mosur Sumantra Chattarji, PhD Ambassador D M Mulay  
Jeffrey S. Nye, MD, PhD
Vice President
Neuroscience Innovation & Scientific Partnership Strategy
Johnson and Johnson Innovation
Sridhar Mosur
President
Stabilis, Inc.
Sumantra Chattarji, PhD
Professor
NCBS- TIFR
Ambassador D M Mulay
Consul General of India
 
 
* Speakers and Program subject to change

 




USA Indiachamber of Commerce Contact

Overview

USA India Chamber of Commerce has created a BioPharma ecosystem where all stakeholders: Industry, Academia, Investors and Policy Makers meet to learn, share, deliberate and network. This unique platform creates mutually beneficial opportunities and relationships for the global BioPharma industry.

USAIC’s annual BioPharma & Healthcare Summit has become THE BioPharma event in the world for senior executives focused on Drug Discovery & Development, Partnering, Licensing, External Research, Translational Research, Medical Devices, Healthcare, Innovation and Emerging Markets.

View Event Brochure



USA Indiachamber of Commerce Contact


Highlights
  • Annual high profile summit of established and emerging BioPharma, Medical Devices, Healthcare companies, Venture Capitalists, Policy Makers and Academia from the US, Europe and India
  • Annual R&D spend of just the Advisory Board members in excess of $25 billion
  • THE Bio Pharma event in the world focused on BioPharma, Medical Devices and Healthcare
  • 5+ Networking Opportunities with Industry Leaders, Investors, Academicians and Policy Makers
  • Maximize collaborations with the world’s leading collaborators
  • Learn about new models in R&D, partnering and commercial models - DIRECTLY from major implementers
  • Meet & Network with the top global industry thought leaders, investors, academicians and policy makers at one location
  • Business insights from the industry’s top thought leaders and decision makers
  • Annual summit provides continuity and results by bringing all stakeholders together
  • An ideal platform to Learn Share Network and Benefit
  • A forum open only to senior executives

View Event Brochure



USA Indiachamber of Commerce Contact

Hyatt Regency Cambridge Venue

Boston Marriott Cambridge
Two Cambridge Center
50 Broadway
Cambridge
Massachusetts 02142 USA
Tel : 617 494-6600

Marriott Cambridge hotel in Kendall Square is centrally located and offers easy, quick access to downtown Boston. Situated near the scenic Charles River, the Marriott Cambridge is just minutes away from Harvard University, MIT and Boston University. Located near Massachusetts General Hospital, this hotel in Cambridge, Massachusetts is easily accessible from Boston Logan Airport, I-93 and the subway.
Accomodation
Limited number of rooms have been held at the Marriott Cambridge at the Summit room rate of $289 plus applicable taxes.
The rate includes In Room Internet.
Room block is available for June 9 - June 13                                       
Rooms are issued on a first come first served basis and available until May 31, 2015. All reservations must be made individually online or by telephone for Marriott Cambridge Hotel   
or call 1(800) 228-9290. Please tell the operator about the USA-India Chamber of Commerce Room Block

PARKING
  • Valet parking, fee: 45 USD daily
  • Off-site parking, fee: 40 USD daily

View Event Brochure



USA Indiachamber of Commerce Contact

Registration fee: $990
Registration rates will go up soon.

Participants can register online.
Payment can be made by credit card.

No walk-ins or at the door registration.

Summit open only to Senior Executives, Entrepreneurs, VCs, Investment Bankers, Private Equity Firms, Academia and Policy makers in the Life Sciences industry (Pharmaceuticals, Biotechnology, Medical Devices and Healthcare).

Restricted entry for Service firms, Sales personnel and Consultants. USA-India Chamber of Commerce reserves the right to decline any registration without assigning any reason

View Event Brochure



USA Indiachamber of Commerce Contact

Dr. Jitendra Singh Prof. K. Vijay Raghavan
   
Dr. Jitendra Singh
Minister of State (IC) for Science & Technology and Earth Sciences
Minister of State in the Prime Minister’s Office and
Personnel, Public Grievances and Pensions
Government of India
Prof. K. Vijay Raghavan
Secretary
Department of Biotechnology
   
Message from Srikant K Jena Message from Srikant K Jena
View Event Brochure



USA Indiachamber of Commerce Contact

Participants comments  

Dr. Paul Stoffels, Group Chairman of Global Pharma and Chief Scientific Officer, Johnson & Johnson
I would like to thank you for the exceptional successful meeting yesterday in Cambridge. 
Me and my team made a significant number of new contacts. We will start working on all of the follow ups.  I look forward to a continued participation in your organization.

Dr. Elias Zerhouni, President, Global R&D, Sanofi
I really want to do this (participate in the USAIC summit). USAIC initiatives are really very critical for the industry!

Dr. Martin Mackay, Executive Vice President- Global R&D, Alexion Pharmaceuticals
This is a terrific meeting. It has really been incredible to watch the summit grow and actually thrive now. The meeting is well oversubscribed. We had to turn away over hundred people. Although we call this meeting US India, diseases know no boundaries. It is going to make a global impact on things we work and decide on today at the summit.

Dr. G.N. Singh, Drug Controller General of India, Central Drug Control Organization
Thank you for all your kind support in making the deliberations fruitful. I mentioned the outcome to our Health Secretary. He was very happy. With regards and best wishes to your team for their tireless efforts in making this summit successful.

Bahija Jallal, PhD;  Executive Vice President, MedImmune
Thank you for inviting me to be a part of the US India BioPharma & Healthcare Summit.  I very much enjoyed my role and the engaging panel discussions.  It was also a pleasure to reacquaint with my former colleague Martin Mackay.
The summit was a great success and I was happy to be a part of it.

Dr. William Chin, Executive Vice President- Scientific and Regulatory Affairs, PhRMA
This summit is a terrific meeting. It is an essential meeting to have a forum that allows all of us from different sectors- government, industry, academia, investors and patient groups to think deeply about how we can really use this ecosystem to do a lot better; How do we create new drugs, devices, diagnostics for our patients in a faster more efficient effective way.

Hari S Bhartia, Co - Chairman & Managing Director, Jubilant Life Sciences
For the last five years, I have observed the annual US-India BioPharma & Healthcare Summit play a significant role in forging partnerships between the global BioPharma and Indian companies.  USAIC has been able to involve and engage Global BioPharma R&D leaders and key stakeholders to foster innovation. These interactions have led to innovative business ideas, new partnerships and business.

Dr. Mikael Dolsten, President Worldwide R&D, Pfizer
Biopharma and biotech companies have a strong interest in the continued growth of India’s innovative drug research industry – to improve public health in India and the world.  Pfizer has a global network of academic alliances and strategic partnerships, including collaborations with several Indian Biopharma companies and CROs, to accelerate our delivery of differentiated medicines.  This summit, organized by the USA-India Chamber of Commerce, by connecting companies with high quality drug designers and developers in India, is valuable to the industry and to patients.

Dr. Michael Rosenblatt, Executive Vice President & CMO, Merck & Co.
I write to congratulate you on a most successful USA-India conference. The presentations and panel discussions were excellent, as was the networking. I look forward to next year’s meeting.

Tsutomu Une, PhD; Corporate Advisor, Daiichi Sankyo
Thank you for your warm hospitality during the conference.  I could participate in the conference without any concern because of your hospitality and actually enjoyed very much meeting the people.
Thank you again and look forward to meeting you again.

Andrew Plump, MD, PhD; Research & Translational Medicine, Deputy to the President of Global R&D, Sanofi
Thank you for the invitation to participate in yesterday’s BioPharma Summit.  It was a terrific event.  Your spirit and good-nature made it so.  It was a pleasure to be involved and to have met you and many of the other participants.

Dr. Srinath Reddy, President, Public Health Foundation of India
I would like to thank you again for the opportunity to participate in the excellent summit hosted by you. The superb content, delivered through a well-structured and efficiently time managed agenda, offered me much to learn. Congratulations on a stellar event which owes its success to your outstanding leadership.

Raju Kucherlapati, PhD; Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School
Karun:  Congratulations on another wonderful Summit.  I was very pleased to see Vijay Raghavan to be engaged throughout the meeting and he was very articulate.  I thought that all of the panels were outstanding and you brought great people to participate.  The talk by Bob Langer was very enjoyable, entertaining and an excellent example of repeated innovation.  Thank you for asking me to be a part of this great enterprise.

Vijay Kuchroo, PhD; Principal Investigator, Kuchroo Laboratory, Brigham & Women's Hospital
It was wonderful to see you and the team that you have developed in organizing the summit.  I thought the summit was well attended with a lot of discussions in the summit and on the side-lines. I certainly got to meet a number of people with whom I will be doing some work.  Therefore you should be very proud of yourself; the summit has served the purpose.

Dr. Ramesh Deka, former Director, All India Institute of Medical Sciences
Many thanks. It was indeed a big success of your initiative with the US India BioPharma Summit on the collaborative health care.

Dr. Willard Dere, former Senior Vice President & International CMO, Amgen 
Others stated it very clearly yesterday, and I wish to reiterate it by email. Thank you for your tremendous work in fostering closer collaboration and true partnership.  I found the meeting to be energizing, fun, and useful.  I know it takes hundreds/thousands of hours of preparation, and I appreciate your dedication and commitment to a higher cause.

Dr. John Leonard, former Senior Vice President Pharma R&D, AbbVie 
As the pharmaceutical industry continues to globalize, forums such as USAIC’s US-India BioPharma & Healthcare Summit are very valuable to fully realize the Research and Development potential both in India and working with Indian companies. 

Peter Mueller, PhD; former Executive Vice President, Vertex Pharmaceuticals
You did a fantastic job!!! It's a pleasure to work with you and see the summit grow year by year! 

Dr. Ivan Gergel, former Executive Vice President R&D, Endo Pharmaceuticals
I thought that the summit was a great success. Thank you for the opportunity to be a part of it,

Prof. Nirmal K. Ganguly, Chairman JIPMER
Thank you very much for inviting me to attend the US-India BioPharma & Healthcare Summit 2011. It is one of the best which I have ever attended. Please accept my congratulations.

K.V. SubramaniamPresident & CEO, Reliance Life Sciences 
The innovation-driven ecosystem fostered by the USA-India Chamber of Commerce has led to meaningful research and technology partnerships between global and Indian companies. I have been involved with this platform for the last few years and it is a great feeling to see it evolve as the Summit of Choice for global research and technology leaders and investors..

Davinder Brar, Chairman, GVK Bio Sciences
The Summit was a resounding success and this one event will add much more to the furtherance of US– India business than many of the delegations which are undertaken for the same purpose.

The quality of scientific talent assembled by you was superb and I still wonder how you manage to pull off such a thing !!! It is rare to see heads of global pharma companies come together for a common cause in such large numbers. Overall the setting was excellent, attendance impressive and the quality of discussions very thought provoking. The party was refreshingly energetic till the late evening. Once again thanks for all your unceasing efforts.

Dr. Dinesh Patel, Chief of Arthroscopic Surgery, Associate Clinical Professor, Harvard Medical School, Massachusetts General Hospital
Once again you made most wonderful meeting.
Wealth of good people but the best was passionate people who believed in cause and your passion.
Thank you for making me part of your journey of globalization-ideas and actions to help the needy thru meeting of minds such as this.

Alpna Seth, PhD; Vice President, Biogen Idec
Just wanted to say congratulations for organizing and executing an outstanding meeting- in every way- content, participants, speakers, logistics, overall set up. Really a great job done by you and your staff. 

Ansbert Gadicke, Managing Director, MPM Capital
Thank you for including me. The event was spectacular, I am deeply impressed by what you have been able to put together!

Viren Mehta, Managing Member, Mehta Partners LLC
You organize a productive format for good people to do good things together.  Thank you for including me.

David Farb, Professor and Chair of Pharmacology, Boston University School of Medicine
Many thanks for organizing such a fascinating summit meeting. I found the breakfast session and panel discussions thought provoking as they illustrated great opportunities for biomedical science industrialization within India.

Vipin Suri, Entrepreneur in Residence, Atlas Venture; Head of Biology, Raze Therapeutics
I wanted to congratulate you, your team and your partners on a fantastic summit on Friday.  It was my first time to the summit, and I can't fathom how you managed to get an absolutely stellar group of people together for the meeting, and also to get them to talk openly about challenges and opportunities in healthcare not just in India, but in general.  Very impressive. I met some great folks, and learnt a lot of things to think about.  Thanks for inviting me.

Debasish Roychowdhury, MD; former Chief Oncology Officer, Sanofi
Karun –congratulations on a very good conference. You have the magic touch –getting people together and giving them a safe harbor for open discussions. I was also very fortunate to be in the audience to hear Dr. Bhan. What an inspirational speech – I would love to hear it again and again and get the inspiration.

Joshua Berlin, Executive Director, New Ventures, BioCentury Publications
Karun, congrats on another great event. Good discussions and lots of energy in the room.

Sri Mosur, CEO, Tanroe Inc.
As Merv Turner, put it, we did entertain the audience as well as educate them on the dynamics of the industry. 
Thank you for the opportunity to participate in such a distinguished forum, I truly enjoyed the very open interactions. I look forward to the next meeting as well as personal interactions during the course of our professional endeavors.

Karun, thanks for pulling together a wonderful show.. it can only get better going forward…

Glenn Kazo, President, Prolong Pharmaceuticals
I want to sincerely thank you for inviting me to US-India BioPharma Summit and specifically for suggesting my participation on the External R&D Strategy Session.  I was very pleased with the high quality of the meeting and the candid discussions among attendees.  This was much more than a US-India conference, it covered the entire gamut of global pharmaceutical issues, opportunities and challenges in a very productive and intense 1 day meeting.  Thank you for inviting me and I look forward to participating in future meetings.   

Barry Mangum, PharmD, FCP; Director Clinical Pharmacology, Duke Clinical Research
I found the Boston meeting one of the best conferences of my year. Your organizational skill was excellent and found the content most informative. 

James Thomas, Co-founder & Partner, Thomas, McNerney & Partners
Thanks to you and your team for an excellent day and evening yesterday. I found the meeting very helpful and enjoyable. 

Richard Connell, PhD; Vice President, Pfizer
It was a stimulating event and I think everyone enjoyed the opportunity to discuss and debate new ways to frame and address the key issues of people, productivity, innovation and risk.

Senior Vice President R&D, Amgen
I wanted to drop you a short note to thank for such a wonderful meeting. The content and networking opportunity were beyond any expectation that I had going into the experience. Over the past several days I have reviewed the Position Paper and think that it is a tremendous contemporary analysis of the business. 
Finally, I really appreciated the dinner and all of the toasts that were exchanged with dessert. What a collegial group of professionals!

Dean, Tufts University School of Medicine
I thought the meeting was a great success and I was honored to be part of it. As a result of the meeting, we made some important contacts with both the Indian government and a number of companies. These contacts have the potential to help Tufts achieve several of our objectives.

I very much appreciate all the efforts you have made.

Ramesh Kumar, CEO, Onconova
I greatly benefited from attending this conference. The program was well organized.

Chief of Staff to the President, Pfizer Global R&D
Many thanks Karun. Super summit yesterday. You out did yourself once again this year - it was a fabulous agenda and a lot of super discussions.

Jay Knowles, Head-Platforms, Strategic Alliances, Novartis Institutes of Biomedical Research
Many thanks for inviting me to your conference today. It was definitely rewarding and gave me great hope for the long-term future of India.

Tom D’Ambra, former Chairman & CEO, AMRI
Congratulations on another successful USA-India Chamber of Commerce event. I enjoyed seeing you again, and really appreciated the networking opportunities you facilitated. Thank you for involving me and AMRI in the event.

John Reynders, Chief Information Officer, Moderna Therapeutics
Thank you so much for inviting me to the US-India BioPharma Summit - it was a wonderful event! I also very much appreciated being part of the R&D breakfast discussion where I had the opportunity to share AstraZeneca's experience in creating the virtual neuroscience team. It was very impressive the many distinguished guests you brought together to the summit.
Suri Venkatachalam, PhD, CEO & Managing Director, Connexios Life Sciences
Congratulations once again for organizing such a wonderful event. Many thanks for inviting me. I truly enjoyed the event.

Jeff Elton, Chairman, KEW Group
I had fun and benefitted from the meeting as always 

Sidhant, Founder & CEO, Sana Care (Start up Company)
Thanks for inviting me to the conference. It was amazing with great panels and people. I met Amar, Kiran and Dr. Bhan and will follow-up with them. Hopefully, things will work out.

Ira M. Herman, PhD, Professor and Director, Tufts University School of Medicine
Congratulations on a wonderful day.. on every level!! I look forward to our continued workings together...

Grannum R. Sant, MD, FRCS, FACS; Vice President, Genzyme
Outstanding meeting yesterday and congratulations on your organization and execution! All your hard work and planning bore fruit.

Thanks again for extending the invitation to me– I learnt a lot and also had an opportunity to network with the movers and shakers (both US and India). Bill Chin did an excellent job as emcee and all the panel discussions were informative, cutting-edge and relevant.

Dr. Mehul Mehta, Chief Strategy Officer, Partners Harvard Medical International
I want to compliment you on a really terrific & high-caliber meeting. Thank you for inviting me. The level of the discussions was superb and the organization was superb.

L J Botticelli, PhD; Chief Business Officer, School of Medicine & University Advancement, Tufts University
I write to congratulate you on a highly successful Summit. To be sure, I found it most productive and of particular value to our efforts at the Tufts Institute for Biopharmaceutical Partnerships.

Too, thank you very much for the opportunity to actively participate in the Industry-Academic Partnership Strategy Session. I enjoyed the discussion and appreciated the varied perspectives to forming innovative global partnerships. Moreover, it confirmed - straightaway - the Tufts strategy to engage proactively in our 'pharma arbitrage' approach. The networking which followed was beneficial. Again, many thanks. I look forward to participating again, next year.

Sourav Basu, Vice President, TCG Life Sciences 
I am attending the meeting for past 3 years now and see a high value in this wonderful summit. Looking forward to the next summit.

R.K. Suri, Chief Executive- Biologicals, Panacea Biotec
At the outset I must thank you for organizing such an eventful meeting of this scale and ensuring presence of who’s who in Boston. Both Sumit Jain and myself are highly appreciative of the personal care taken by you for this mammoth task. High quality meeting indeed! 


View Event Brochure



USA Indiachamber of Commerce Contact

 
Pharmasia News Pharmasia News Biospectrum India Online The Pink Sheet
© 2007 - 2014 USA India Chamber of Commerce Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us